|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Investment in related party investment fund, at fair value | ||||||||||||||||||||
| Fixed maturity investments, at fair value | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||||||
| Reinsurance balances receivable | ||||||||||||||||||||
| Reinsurance recoverable on unpaid loss and loss adjustment expenses | ||||||||||||||||||||
| Deferred acquisition costs | ||||||||||||||||||||
| Unearned premiums ceded | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Loss and loss adjustment expense reserves | ||||||||||||||||||||
| Unearned premium reserves | ||||||||||||||||||||
| Reinsurance balances payable | ||||||||||||||||||||
| Funds withheld | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity | ||||||||||||||||||||
| Preferred share capital (par value $0.10; none issued) | ||||||||||||||||||||
| Ordinary share capital (par value $0.10; issued and outstanding, xxx) (2025: par value $0.10; issued and outstanding, xxx) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
